GlassScriptPhysician profile
Jessica Cooley
NPI 1720482441
$6,712.95
in general payments reported to CMS, 2019-2025
36 companies · $1,181 in 2025
The $1,181 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,328 · 2022: $1,698 · 2023: $1,212 · 2024: $1,293 · 2025: $1,181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,686.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,243.75 | 2021-2025 | |
| Novo Nordisk INC | $809.80 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $639.82 | 2021-2024 | Jardiance |
| Glaxosmithkline, LLC. | $531.33 | 2021-2025 | Trelegy Ellipta |
| Amgen INC. | $388.60 | 2021-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $374.05 | 2021-2025 | |
| Astellas Pharma US INC | $340.12 | 2023-2025 | Veozah, Myrbetriq |
| Novartis Pharmaceuticals Corporation | $256.15 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $224.24 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $215.91 | 2021-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $209.34 | 2021-2025 | Freestyle Libre 3, Assurity |
| Sanofi-Aventis U.S. LLC | $206.43 | 2021-2023 | |
| Lilly USA, LLC | $184.40 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $132.24 | 2022 | |
| Exact Sciences Corporation | $104.05 | 2023-2024 | Cologuard Collection Kit |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.